| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 770,081 | 627,946 | 561,811 | 913,765 | | Cost of Revenue | 636,642 | 494,240 | 462,630 | 875,779 | | | Gross Profit | 133,439 | 133,706 | 99,181 | 37,986 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 44,429 | 61,139 | 65,452 | 75,662 | | Non Recurring |
-
|
-
|
-
| 11,686 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 89,010 | 72,567 | 33,729 | (49,362) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 116,550 | 72,567 | 33,729 | (49,362) | | Interest Expense | 3,110 | 2,738 | 3,111 | 3,382 | | Income Before Tax | 113,440 | 69,829 | 30,618 | (52,744) | | Income Tax Expense | 41,313 | 28,403 | 12,630 | (22,287) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 72,127 | 41,426 | 17,988 | (30,457) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 72,127 | 41,426 | 17,988 | (30,457) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $72,127 | $41,426 | $17,988 | ($30,457) |
|
1.52% Nasdaq 
Income Statement
